CN1709865A - High-optical-purity chiral beta-alkamine compound, preparing method and its use - Google Patents
High-optical-purity chiral beta-alkamine compound, preparing method and its use Download PDFInfo
- Publication number
- CN1709865A CN1709865A CN 200510027249 CN200510027249A CN1709865A CN 1709865 A CN1709865 A CN 1709865A CN 200510027249 CN200510027249 CN 200510027249 CN 200510027249 A CN200510027249 A CN 200510027249A CN 1709865 A CN1709865 A CN 1709865A
- Authority
- CN
- China
- Prior art keywords
- beta
- chirality
- cdcl
- nmr
- optical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
This invention involves high optical purity chiral beta-amino alcohols compounds, its method of preparation and function. The structure formula of chirality beta-amino alcohols compounds is (A) or (A'). Thereinto, R1 is straight-chain and branched chain or aryl alkyl that carbon atomicity is 1-16,or naphthene that carbon atomicity is 3-6; R2 is straight-chain and branched chain or aryl alkyl that carbon atomicity is 1-12, naphthene that carbon atomicity is 3-6, or phenyl replaced by R3 or R4; R3 or R4 is hydrogen, alkyl that carbon atomicity is 1-6, halogen, alkoxy that carbon atomicity is 1-5,or OCOR5; mentioned halogen is F, Cl or Br; R5 is alkyl that carbon atomicity is 1-6.This compound can get rid of chirality tertiary butyl sulphinyl further and get high optical purity chirality beta-amino alcohols compounds.
Description
Technical field
The present invention relates to chiral beta-alkamine compound, new synthetic method, and their purposes.
Background technology
The chirality beta-alkamine is the very useful compound of a class, much has physiologically active.They are the important synthons in some drug molecules and the natural product molecule synthesis, also are important chiral ligand and chirality assistant agent in a lot of asymmetric reactions.((a) Lee, H.-S.; Kang, S.H.Synlett 2004,1673. (b) Ager, D.J.; Prakash, I.; Sehaad, D.R.Chem.Rev.1996,96,835. (c) Pu, L; Yu, H.-B.Chem.Rev.2001,101,757.) therefore, the high-efficiency synthesis method of development preparation chirality beta-alkamine all is subjected to various countries organic chemists' attention always.(Bergmeier, S.C.Tetrahedron 2000,56, and 2561.) theoretically, the tetramethyl ethylene ketone of aldehyde and imines (Pinacol) class cross-coupling is the most convenient of preparation beta-alkamine compound, direct method.But in fact owing to be difficult to suppress or avoid self linked reaction of under reaction conditions aldehyde or imines, the general difficult cross-coupling of realizing aldehyde and imines is said nothing of the stereoselectivity of control reaction.That is to say that the chemo-selective that will obtain and stereoselectivity are very difficult, especially stereoselectivity.At present the example of these class methods of bibliographical information is also few, and mostly only is used for beta-alkamine compound synthetic of some racemizations.((a) Roskamp, E.J.; Pedersen, S.F; J.Am.Chem.Soc.1987,109,6551. (b) Shono, T.; Kise, N.; Fujimoto, T.Tetrahedron Lett.1991,32,525. (c) Guijarro, D.; Yus, M.Tetrahedron 1993,49,7761. (d) Machrouchi, F.; Namy, J.L.Tetrahedron Lett.1999,40,1315. (e) Shimizu, M.; Iwata, A.; Makino, H.Synlett 2002,1538.) comparatively successful example is the tricarbonyl chromium that utilizes planar chiral of development in recent years or the cross-coupling of ferrocene-containing compound, but the scope of application of reaction is very narrow, only is suitable for a handful of aromatic substrate and ferrocene substrate.((a) Taniguchi, N.; Uemura, M.J.Am.Chem.Soc.2000,122,8301. (b) Tanaka, Y.; Taniguchi, N.; Uemura, M.Org.Lett.2002,4,835. (c) Tanaka, Y; Taniguchi, N.; Kimura, T.; Uemura, M.J.Org.Chem.2002,67,9227.) therefore, the method that develops new high-efficient simple ground synthesis of chiral beta-alkamine and derivative thereof more and more receives chemists' concern.
Summary of the invention
The purpose of this invention is to provide a kind of high-optical-purity chiral beta-alkamine compound;
Another object of the present invention provides a kind of high-optical-purity chiral beta-alkamine compound of preparing
Novel synthesis;
Purpose of the present invention also provides a kind of purposes for preparing high-optical-purity chiral beta-amino alcohol compound.
High-optical-purity chiral beta-alkamine compound of the present invention has following structural formula:
Perhaps
R wherein
1Be the fatty substituting group of non-fragrance, R
2Then can be aromatic substituent, alkyl substituent that also can right and wrong fragrance, the fatty substituting group of non-fragrance described here be straight chained alkyl, have alkyl, the cycloalkyl of side chain or aryl; That is to say that reaction substrate aldehyde 1 is non-aromatic aldehyde, chirality N-tertiary butyl sulfinyl aldimine 2 then can be fragrance or fatty.Specifically, R
1=C
1-16Straight chain, have the alkyl of side chain or aryl or C
3-6Cycloalkyl; R
2=C
1-12Straight chain, have the alkyl of side chain or aryl or C
3-6Cycloalkyl, or R
3Or R
4The phenyl that replaces; R
3Or R
4=H, C
1-6Alkyl, halogen, C
1-6Alkoxyl group, or OCOR
5Described halogen is F, Cl or Br; R
5=C
1-6Alkyl.
Novel synthesis of the present invention can be represented by following type reaction formula:
R wherein
1=C
1-16Straight chain, have the alkyl of side chain or aryl or C
3-6Cycloalkyl; R
2=C
1-12Straight chain, have the alkyl of side chain or aryl or C
3-6Cycloalkyl, or R
3Or R
4The phenyl that replaces; R
3Or R
4=H, C
1-6Alkyl, halogen, C
1-6Alkoxyl group, or OCOR
5Described halogen is F, Cl or Br; R
5=C
1-6Alkyl.
But novel synthesis classified description of the present invention is as follows:
Committed step of the present invention is that the cross-coupling reaction of aldehyde 1 and optically pure chirality N-tertiary butyl sulfinyl aldimine 2 generates chiral beta-alkamine compound 3.With samarium diodide (SmI
2) as reaction reagent, in organic solvent tetrahydrofuran (THF) and the trimethyl carbinol (
tBuOH) or under the existence of methyl alcohol (MeOH) ,-78 ℃~-10 ℃ is temperature of reaction, react and do not wait in 1 to 20 hour, can obtain structural formula with the productive rate of 60-99% and be
Perhaps
Chiral beta-alkamine compound 3, R wherein
1And R
2As previously mentioned.In this reaction, when the consumption of N-tertiary butyl sulfinyl aldimine 2 was 1.0 mmoles, the consumption of aldehyde 1 was the 1.0-3.0 mmole, samarium diodide (SmI
2) consumption is the 1.5-2.2 mmole, the trimethyl carbinol (
tBuOH) or the consumption of methyl alcohol (MeOH) also be the 1.5-2.2 mmole.
In the above-mentioned reaction, the diastereoselectivity ratio (dr) of resulting chiral beta-alkamine compound 3 can reach 88: 12~and>99: 1.
The chirality beta-alkamine derivative 3 (HCl, the CF under acidic conditions that obtain among the present invention
3COOH etc.) reaction just can remove chirality N-tertiary butyl sulfinyl in 1-10 hour easily, received the chirality beta-alkamine
Further carry out the acetyl glycosylation reaction, can obtain its acetyl derivative with the yield of 85-99%
The enantioselectivity of reaction is to record with chirality HPLC by its acetyl derivative, reaches 90~99%ee.
Concrete experimental result is listed as follows:
The cross-coupling reaction of table 1, samarium diodide inductive aldehyde and chirality N-tertiary butyl sulfenimide
Numbering | R 1 | ????R 2 | Product 3 | Yield (%) | ??dr | ??ee(%) |
?1 ?2 ?3 ?4 ?5 ?6 ?7 ?8 ?9 ?10 ?11 ?12 ?13 ?14 ?15 ?16 | 4-CH 3C 6H 44-CH 3C 6H 44-CH 3C 6H 44-CH 3C 6H 44-CH 3C 6H 4Ph 4-FC 6H 44-ClC 6H 44-BrC 6H 44-AcOC 6H 44-CH 3OC 6H 43,4-(MeO) 2C 6H 32,4-(MeO) 2C 6H 3 iPr PhCH 2CH 2CH 3(CH 2) 4 | ??? iPr ????C 6H 11????(Et) 2CH ????n-C 5H 11????PhGH 2CH 2??? iPr ??? iPr ??? iPr ??? iPr ??? iPr ??? iPr ??? 1Pr ??? iPr ??? iPr ??? iPr ??? iPr | ????3a ????3b ????3c ????3d ????3e ????3f ????3g ????3h ????3i ????3j ????3k ????3l ????3m ????3n ????3o ????3p | ????92 ????90 ????73 ????90 ????95 ????86 ????89 ????71 ????70 ????82 ????84 ????90 ????73 ????88 ????87 ????95 | ??>99∶1 ??99∶1 ??>99∶1 ??91∶9 ??88∶12 ??99∶1 ??98∶2 ??99∶1 ??>99∶1 ??>99∶1 ??>99∶1 ??>99∶1 ??>99∶1 ??>99∶1 ??96∶4 ??98∶2 | ??98 ??>99 ??99 ??95 ??95 ??97 ??>99 ??98 ??>99 ??>99 ??>99 ??>99 ??>99 ??98 ??>99 ??97 |
Method of the present invention is carried out cross-coupling reaction with aldehyde and chirality N-tertiary butyl sulfinyl aldimine under the samarium diodide condition, not only easy, direct, and efficient.Here, the chirality N-tertiary butyl sulfinyl in the imines is the key of inducing the linked reaction highly-solid selectively.Because the wide application range of substrates of reaction, the diastereoselectivity ratio (dr) and the enantioselectivity (ee) of product are very high, therefore have good practicability, are a kind of fabulous methods for preparing high-optical-purity chiral beta-alkamine compound.The high-optical-purity chiral beta-alkamine compound that obtains can be advantageously used in the preparation of high-optical-purity chiral beta-amino alcohol.
Embodiment
To help to understand the present invention by following embodiment, but not limit content of the present invention.
Embodiment 1
3a's is synthetic
In 25mL Schlenk bottle, with 1.0mmol samarium diodide (SmI
2) tetrahydrofuran (THF) (THF) solution (5mL) be cooled to-78 ℃, drip corresponding (the R)-chiral imines of 0.5mmol, 6mL tetrahydrofuran (THF) (THF) solution of the corresponding aldehyde of 1.0mmol and the 1.0mmol trimethyl carbinol, reacted 4 hours, the cancellation of 5mL saturated aqueous sodium thiosulfate, ethyl acetate extraction, saturated common salt water washing, anhydrous sodium sulfate drying, concentrate, purification by silica gel column chromatography obtains corresponding cross-coupling product 3a fast, productive rate 92%, experimental result sees table 1 for details.
3a[α]
D 20=-48.2°(c0.80,CHCl
3);
1H?NMR(300MHz,CDCl
3):δ0.94(d,3H,J=5.1Hz),0.96(d,3H,J=5.1Hz),1.22(s,9H),1.49(m,1H),2.07(br,1H),2.33(s,3H),3.61(br,1H),3.68(d,1H,J=5.7Hz),4.45(t,1H,J=4.8Hz),7.14(d,2H,J=8.1Hz),7.29(d,2H,J=8.1Hz);FT-IR(KBr,cm
-1):3346,1463,1031;ESI-MS(m/z,%):298.3(M
++H);
13C?NMR(75MHz,CDCl
3):δ18.26,19.32,21.09,22.57,30.17,55.96,60.42,78.82,128.39,129.31,135.39,137.85;HRMS?for?C
16H
27NO
2SNa(M
++Na):calcd.320.1655,found:320.1634.
Embodiment 2
3b's is synthetic
Operate the same, productive rate 90%.
3b[a]
D 20=-53.8°(c1.35,CHCl
3).
1H?NMR(300MHz,CDCl
3):δ1.24(d,6H,J=7.2Hz),1.24-1.26(m,4H),1.72-1.90(m,6H),2.34(s,3H),3.66(dd,1H,J=4.2,7.2Hz),3.77(d,1H,J=5.7Hz),4.47(t,1H,J=4.9Hz),7.15(d,2H,J=8.0Hz),7.28(d,2H,J=8.0Hz);FT-IR(KBr,cm
-1):3346,1463,1031;ESI-MS(m/z,%):338(M
++H);
13C?NMR(75MHz,CDCl
3):δ21.12,22.63,25.59,25.86,26.33,28.27,29.55,39.67,56.03,60.00,78.05,128.38,129.36,135.56,137.80;HRMS?for?C19H31NO2SNa(M
++Na):calcd.360.1967,found:360.1974.
Embodiment 3
3c's is synthetic
Operate the same, productive rate 73%.
3c[α]
D 20=-36.0°(c1.05,CHCl
3);
1H?NMR(300MHz,CDCl
3):δ0.85(q,6H,J=3.0Hz),1.19(s,9H),1.21-1.56(m,5H),1.76(br,1H),2.33(s,3H),3.64(d,1H,J=5.4Hz),3.85(br,1H,),4.45(t,1H,J=5.4Hz),7.15(d,2H,J=8.1Hz),7.28(d,2H,J=8.1Hz);FT-IR(KBr,cm
-1):3370,3336,2967,1513,1466,1033;ESI-MS(m/z,%):326.3(M
++H);
13C?NMR(75MHz,CDCl
3):δ10.50,10.61,20.01,21.10,21.29,22.59,41.69,56.03,60.42,74.90,128.30,129.40,135.77,137.86;HRMS?for?C
18H
31NO
2SNa(M
++Na):calcd.348.1968,found:348.1989.
Embodiment 4
3d's is synthetic
Operate the same, productive rate 90%.
3d[α]
D 20=-30.2°(c0.30,CHCl
3);
1H?NMR(300MHz,CDCl
3):δ0.86(t,3H,J=6.9Hz),1.12-1.20(m,2H),1.28(s,9H),1.29-1.36(m,6H),2.34(s,3H),3.78(s,1H),3.96(t,1H,J=4.5
Hz),4.35(dd,1H,J=3.6,5.4Hz),7.15(d,1H,J=7.8Hz),7.23(d,2H,J=7.8Hz);FT-IR(KBr,cm
-1):3300,2959,2919,1462,1046;ESI-MS(m/z,%):326.2(M
++H);
13C?NMR(75MHz,CDCl
3):δ13.90,21.00,22.46,22.58,25.51,31.64,33.29,56.13,62.17,73.60,128.11,129.07,135.23,137.50;HRMS?for?C
18H
32NO
2S(M
++H):calcd.326.2148,found:326.2144.
Embodiment 5
3e's is synthetic
Operate the same, productive rate 95%.
3e[α]
D 20=-53.8°(c1.35,CHCl
3);
1H?NMR(300MHz,CDCl
3):δ1.18(s,1H),1.22(s,8H),1.23-1.26(m,1.4H),1.48-1.50(m,1.4H),2.33(s,3H),2.78-2.83(m,2H),2.64-2.67(m,2H),3.95(s,1H),3.99(d,1H,J=6.3Hz),4.37(dd,1H,J=5.1,9.6Hz),7.13-7.28(m,9H);FT-IR(KBr,cm
-1):3377,3024,2857,1047,1038;ESI-MS(m/z,%):360(M
++H);
13C?NMR(75MHz,CDCl
3):δ21.01,22.62,32.17,35.10,56.21,62.26,73.02,125.76,128.09,128.22,128.27,128.33,129.19,135.10,137.67,141.70;HRMS?for?C
21H
30NO
2SNa(M
++Na):calcd.360.1992,found:360.1998.
Embodiment 6
3f's is synthetic
Operate the same, productive rate 86%.
3f[α]
D 20=-51.3°(c0.65,CHCl
3);
1H?NMR(300MHz,CDCl
3):δ0.94(t,6H,J=6.9Hz),1.21(s,9H),1.48(m,1H),2.00(br,1H),3.63(br,1H),3.74(d,1H,J=5.7Hz),4.49(dd,1H,J=5.7,4.5Hz),7.31-7.43(m,5H);FT-IR(KBr,cm
-1):3410,3327,2956,1475,1041,699;ESI-MS(m/z,%):284.2(M
++H);
13C?NMR(75MHz,CDCl
3):δ18.29,19.33,22.59,30.17,56.05,60.61,78.85,128.19,128.52,128.64,138.40;HRMS?for?C15H25NO2SNa(M
++Na):calcd.306.1498,found:306.1515.
Embodiment 7
3g's is synthetic
Operate the same, productive rate 89%.
3g[α]
D 20=-42.1°(c1.05,CHCl
3);
1H?NMR(300MHz,CDCl
3):δ0.94(d,3H,J=1.5Hz),0.96(d,3H,J=1.5Hz),1.22(s,9H),1.24-1.27(m,1H),2.12(d,1H,J=2.1Hz),3.61(dd,1H,J=3.9,7.8Hz),3.70(d,1H,J=5.7Hz),4.48(dd,1H,J=5.7,9.3Hz),7.05(d,2H,J=18.1Hz),7.42(d,2H,J=18.1Hz);FT-IR(KBr,cm
-1):2961,2872,1604,1511,1048;ESI-MS(m/z,%):302.2(M
++H);
13CNMR(75MHz,CDCl
3):δ18.34,19.15,22.49,30.21,56.05,60.01,78.99,115.19,115.47,130.25,130.35,134.39,134.44,160.69,163.96;HRMS?for?C
15H
25NO
2SF(M
++H):calcd.302.1584,found:302.1583.
Embodiment 8
3h's is synthetic
Operate the same, productive rate 71%.
3h[α]
D 20=-35.8°(c0.80,CHCl
3);
1H?NMR(300MHz,CDCl
3):δ0.94(d,6H,J=6.6Hz),1.21(s,9H),1.45(m,1H),2.27(br,1H),3.60(m,1H),3.81(m,1H),4.44(m,1H),7.30(dd,2H,J=2.4,6.6Hz),7.36(dd,2H,J=2.4,6.6Hz);FT-IR(KBr,cm
-1):3344,2961,1492,1031;ESI-MS(m/z,%):318.2(M
++H);
13CNMR(75MHz,CDCl
3):δ18.37,19.18,22.53,30.25,56.12,60.11,78.99,128.69,130.03,133.90,137.04;HRMS?for?C
15H
24NO
2SClNa(M
++Na):calcd.340.1108,found:340.1113.
Embodiment 9
3i's is synthetic
Operate the same, productive rate 70%.
3i[α]
D 20=-26.7°(c0.75,CHCl
3);
1H?NMR(300MHz,CDCl
3):δ0.93(d,6H,J=6.9Hz),1.20(s,9H),1.45(m,1H),2.35(d,1H,J=5.1Hz),3.58(m,1H),3.84(d,1H,J=6.6Hz),4.41(dd,1H,J=6.6,4.5Hz),7.30(d,2H,J=8.4Hz),7.45(d,2H,J=8.4Hz);FT-IR(KBr,cm
-1):3340,2958,1487,1031;ESI-MS(m/z,%):362.3(M
++H);
13C?NMR(75MHz,CDCl
3):δ18.37,19.18,22.52,30.25,56.13,60.16,78.98,122.07,130.36,131.60,137.61;HRMS?for?C
15H
24NO
2SBrNa(M
++Na):calcd.384.0603,found:384.0614.
Embodiment 10
3j's is synthetic
Operate the same, productive rate 82%.
3j[α]
D 20=-40.0°(c0.60,CHCl
3);
1H?NMR(300MHz,CDCl
3):δ0.92(d,6H,J=6.6Hz),1.19(s,9H),1.46(m,1H),2.29(s,3H),2.33(br,1H),3.56(br,1H),3.78(d,1H,J=6.0Hz),4.45(m,1H),7.04(d,2H,J=8.4Hz),7.41(d,2H,J=8.4Hz);FT-IR(KBr,cm
-1):3298,3177,2961,1768,1749,1507,1370,1222,1199,1058,1003;ESI-MS(m/z,%):342.1(M
++H);
13C?NMR(75MHz,CDCl
3):δ18.29,19.23,21.09,22.53,30.07,56.03,60.03,78.77,121.52,129.69,136.07,150.23,169.36;HRMS?for?C
17H
27NO
4SNa(M
++Na):calcd.361.1553,found:364.1547.
Embodiment 11
3k's is synthetic
Operate the same, productive rate 84%.
3k[α]
D 20=-38.1°(c1.55,CHCl
3);
1H?NMR(300MHz,CDCl
3):δ0.94(s,3H),0.97(s,3H,),1.22(s,9H),1.25-1.29(m,1H),2.06(d,1H,J=4.2Hz),3.63(m,2H),3.80(s,3H),4.45(t,1H,J=4.8Hz),6.89(d,2H,J=8.7Hz),7.34(d,2H,J=8.7Hz);
FT-IR(KBr,cm
-1):3504,3139,2962,1515,1247,1039,1001;ESI-MS(m/z,%):314(M
++H);
13C?NMR(75MHz,CDCl
3):δ18.23,19.20,22.49,30.13,55.07,55.91,60.19,78.87,113.81,129.65,130.51,159.15;HRMS?for?C16H27NO3SNa(M
++Na):calcd.336.1609,found:336.1607.
Embodiment 12
31 synthesize
Operate the same, productive rate 90%.
31[α]
D 20=-35.2°(c0.55,CHCl
3);
1H?NMR(300MHz,CDCl
3):δ0.96(s,3H),0.99(s,3H,),1.24(s,9H),2.01(d,1H,J=4.2Hz),3.59-3.64(m,2H),3.90(s,3H),4.43(dd,1H,J=5.1,9.6Hz),6.86(dd,1H,J=6.0,8.7Hz),6.99(dd,2H,J=4.8,8.7Hz);FT-IR(KBr,cm
-1):3428,2960,2837,1522,1041,1025;ESI-MS(m/z,%):344(M
++H);
13C?NMR(75MHz,CDCl
3):δ18.07,19.29,22.46,30.06,55.66,55.80,55.88,60.52,78.77,110.93,111.79,120.71,130.98,148.69;HRMS?for?C17H29NO4SNa(M
++Na):calcd.366.1709,found:366.1712.
Embodiment 13
3m's is synthetic
Operate the same, productive rate 73%.
3m[α]
D 20=-49.6°(c0.70,CHCl
3);
1H?NMR(300MHz,CDCl
3):δ0.93(d,3H,J=6.6Hz),0.97(d,3H,J=6.6Hz),1.22(s,9H),1.73-1.80(m,1H),1.94(s,1H),3.68(s,1H),3.79(s,3H),3.84(s,3H),4.13(dd,1H,J=7.5,16Hz),4.47(dd,1H,J=7.5,15Hz),6.46-6.49(m,2H),7.27(dd,1H,J=3.6,8.7Hz);FT-IR(KBr,cm
-1):3541,2964,1612,1071;ESI-MS(m/z,%):344.2(M
++H);
13C?NMR(75MHz,CDCl
3):δ16.31,19.74,22.49,29.67,55.21,55.33,55.77,59.17,78.10,99.12,104.47,119.77,130.95,157.93,160.48;HRMS?for?C
17H
29NO
4SNa(M
++Na):calcd.366.1709,found:366.1706.
Embodiment 14
3n's is synthetic
Operate the same, productive rate 88%.
3n[α]
D 20=-62.8°(c0.50,CHCl
3);
1H?NMR(300MHz,CDCl
3):δ0.91-0.97(m,9H),1.09(d,3H,J=5.1Hz),1.26(s,9H),1.66(d,1H,J=4.8Hz),1.91-1.95(m,1H),2.20-2.25(m,1H),3.16-3.20(m,1H),3.23(d,1H,J=6.6,Hz),3.34(d,1H,J=6.0Hz);FT-IR(KBr,cm
-1):3367,2964,2874,1473,1035;ESI-MS(m/z,%):250.2(M
++H);
13C?NMR(75MHz,CDCl
3):δ16.62,16.79,19.81,20.87,22.70,27.25,29.28,56.10,62.70,78.15;HRMS?for?C12H27NO2SNa(M
++Na):calcd.272.1654,found:272.1657.
Embodiment 15
3o's is synthetic
Operate the same, productive rate 87%.
3o[α]
D 20=-118.8°(c0.30,CHCl
3);
1H?NMR(300MHz,CDCl
3):δ0.68(d,3H,J=6.9Hz),0.98(d,3H,J=6.9Hz),1.26(s,9H),1.66-1.68(m,1H),1.91-2.05(m,2H),2.64-2.69(m,1H),2.87-2.89(m,1H),3.20(dd,2H,J=2.1,9.0Hz),3.31-3.38(m,2H),7.18-7.32(m,5H);FT-IR(KBr,cm
-1):3370,2959,5870,1042;ESI-MS(m/z,%):312.2(M
++H);
13C?NMR(75MHz,CDCl
3):δ18.64,19.69,22.72,28.55,30.25,31.66,55.68,58.09,80.35,125.90,128.35,128.55,141.51;HRMS?C
17H
29NO
2SNa(M
++Na):calcd.334.1811,found:334.1813.
Embodiment 16
3p's is synthetic
Operate the same, productive rate 95%.
3p[α]
D 20=-99.6°(c0.50,CHCl
3);
1H?NMR(300MHz,CDCl
3):δ0.89(dd,6H,J=3.9,6.3Hz),1.02(d,3H,J=6.3Hz),1.26(s,9H),1.27-1.34(m,4H),1.54-1.75(m,4H),2.87(s,1H),3.17
(d,1H,J=3.9Hz),3.24(t,1H,J=6.6,Hz),3.35-3.39(m,1H);FT-IR(KBr,cm
-1):3303,3207,2958,1058,1038,998;ESI-MS(m/z,%):278.2(M
++H);
13C?NMR(75MHz,CDCl
3):δ14.00,19.02,19.58,22.46,22.64,25.49,26.88,30.43,31.60,55.59,58.74,79.99;HRMS?for?C14H31NO2SNa(M
++Na):calcd.300.1968,found:300.1970.
Embodiment 17
Synthesizing of the enantiomer of 3a (ent-3a)
In 25mL Schlenk bottle, tetrahydrofuran (THF) (THF) solution (5mL) of 1.0mmol samarium diodide (SmI2) is cooled to-78 ℃, drip corresponding (the S)-chiral imines of 0.5mmol, 1.0mmol 6mL tetrahydrofuran (THF) (THF) solution of the corresponding aldehyde and the 1.0mmol trimethyl carbinol, reacted 2~4 hours, the cancellation of 5mL saturated aqueous sodium thiosulfate, ethyl acetate extraction, the saturated common salt water washing, anhydrous sodium sulfate drying concentrates, quick purification by silica gel column chromatography, obtain the diastereomer of corresponding cross-coupling product 3a, productive rate 90%, diastereomer ratio (dr) is>99: 1.
ent-3a[α]
D 20=+47.5°(c0.75,CHCl
3);
1H?NMR(300MHz,CDCl
3):δ0.95(d,3H,J=5.1Hz),0.97(d,3H,J=5.1Hz),1.22(s,9H),1.49(m,1H),2.07(br,1H),2.33(s,3H),3.63(br,1H),3.69(d,1H,J=5.7Hz),4.45(t,1H,J=4.8Hz),7.14(d,2H,J=8.1Hz),7.30(d,2H,J=8.1Hz);FT-IR(KBr,cm
-1):3348,1465,1035;ESI-MS(m/z,%):298.3(M
++H);
13C?NMR(75MHz,CDCl
3):δ18.26,19.32,21.10,22.56,30.17,55.95,60.42,78.84,128.39,129.31,135.39,137.87;HRMS?for?C
16H
27NO
2SNa(M
++Na):calcd.320.1655,found:320.1634.
Embodiment 18
Synthesizing of the enantiomer of 3b (ent-3b)
With corresponding (S)-chiral imines is reaction substrate, operate the same, productive rate 87%, diastereomer ratio (dr) is 99: 1.
ent-3b[α]
D 20=+53.2°(c1.20,CHCl
3).
1H?NMR(300MHz,CDCl
3):δ1.24(d,6H,J=7.2Hz),1.24-1.27(m,4H),1.71-1.91(m,6H),2.34(s,3H),3.66(dd,1H,J=4.2,7.2Hz),
3.76(d,1H,J=5.7Hz),4.48(t,1H,J=4.9Hz),7.14(d,2H,J=8.0Hz),7.28(d,2H,J=8.0Hz);FT-IR(KBr,cm
-1):3348,1463,1032;ESI-MS(m/z,%):338(M
++H);
13C?NMR(75MHz,CDCl
3):δ21.14,22.62,25.59,25.88,26.33,28.28,29.56,39.67,56.04,60.01,78.05,128.38,129.37,135.56,137.81;HRMS?for?C19H31NO2SNa(M
++Na):calcd.360.1967,found:360.1974.
Embodiment 19
Synthesizing of the enantiomer of 3c (ent-3c)
With corresponding (S)-chiral imines is reaction substrate, operate the same, productive rate 76%, diastereomer ratio (dr) is>99: 1.
ent-3c[α]
D 20=+35.6°(c1.00,CHCl
3);
1H?NMR(300MHz,CDCl
3):δ0.85(q,6H,J=3.0Hz),1.19(s,9H),1.20-1.55(m,5H),1.76(br,1H),2.33(s,3H),3.63(d,1H,J=5.4Hz),3.84(br,1H,),4.45(t,1H,J=5.4Hz),7.14(d,2H,J=8.1Hz),7.28(d,2H,J=8.1Hz);FT-IR(KBr,cm
-1):3375,3340,1465,1031;ESI-MS(m/z,%):326.3(M
++H);
13C?NMR(75MHz,CDCl
3):δ10.49,10.60,20.01,21.10,21.28,22.59,41.68,56.01,60.43,74.90,128.28,129.38,135.75,137.85;HRMS?for?C
18H
31NO
2SNa(M
++Na):calcd.348.1968,found:348.1989.
Embodiment 20
Synthesizing of chirality beta-alkamine
The compound 3a (0.2mmol) that obtains in the foregoing description 1 is dissolved in the 2.0mL methyl alcohol, adds 0.5mL 4N HCl in 1,4-dioxane (2.0mmol), reacted 30 minutes, and concentrated, the gained solid mixed solvent recrystallization of methyl alcohol and ether, obtain white solid product, yield 91%.
1H?NMR(300MHz,CDCl
3):δ0.91(d,3H,J=6.6Hz),0.94(d,3H,J=6.6Hz),1.24-1.29(m,1H),2.35(s,3H),3.56(dd,1H,J=3.3,8.4Hz),4.35(d,lH,J=3.0
Hz),7.23(d,2H,J=7.8Hz),7.45(d,2H,J=7.8Hz);FT-IR(KBr,cm
-1):3361,3017,2924,1606,1496;ESI-MS(m/z,%):194,195(M
++H);
13C?NMR(75MHz,CDCl
3):δ19.11,19.38,21.23,32.32,58.03,77.93,130.28,130.39,132.10,140.37;HRMS?C
12H
20NO(M
++H):calcd.194.1539,found:194.1539.
Embodiment 21
Synthesizing of chirality beta-alkamine
Operate the same, productive rate 92%.
1H?NMR(300MHz,CDCl
3):δ0.79(d,3H,J=7.8Hz),0.84(d,3H,J=7.8Hz),1.01-1.04(m,1H),1.29-1.52(m,4H),2.35(s,3H),3.89(dd,1H,J=3.0,9.3Hz),4.36(d,1H,J=3.0Hz),7.23(d,2H,J=8.1Hz),7.46(d,2H,J=8.1Hz);
13C?NMR(75MHz,CDCl
3):δ10.24,10.32,20.77,21.28,43.66,58.03,73.33,130.33,130.35,132.75,140.24.
Embodiment 22
Synthesizing of chirality beta-alkamine
Operate the same, productive rate 80%.
1H?NMR(300MHz,CDCl
3):δ0.96-1.77(m,10H),2.38(s,3H),3.61(m,1H),4.37(d,1H,J=9.0Hz),7.26(d,2H,J=8.4Hz),7.45(d,2H,J=8.4Hz);FT-IR(KBr,cm
-1):3360,3023,2925,2853,1500,1032;ESI-MS(m/z,%):234,235(M
++H);
13CNMR(75MHz,CDCl
3):δ21.27,26.69,26.74,27.38,29.96,30.33,41.69,57.63,76.58,130.23,130.39,132.11,140.28;HRMS?C
15H
24NO(M
++H):calcd.234.1852,found:234.1853
Embodiment 23
The ethanoyl product of chirality beta-alkamine is synthetic
In the 5mL methylene dichloride, add the amino alcohol product that obtains among the 0.2mmol embodiment 17, the 2mmol triethylamine produces a large amount of white cigarettes, stirs to become settled solution in ten minutes, adds the 2mmol diacetyl oxide, the DMAP of catalytic amount, stirred overnight at room temperature.With the 3mL washing, the NaCl saturated aqueous solution is washed, and anhydrous sodium sulfate drying, rapid column chromatography obtain the product of diacetyl, yield 91%.
[α]
D 20=+153.6(c0.17,CHCl
3);
1H?NMR(300MHz,CDCl
3):δ0.91(d,3H,J=6.6Hz),0.99(d,3H,J=6.6Hz),1.77-1.83(m,1H),1.91(s,3H),1.94(s,3H),2.32(s,3H),4.99(dd,1H,J=6.6,12.6Hz),5.22(dd,1H,J=5.4,8.7Hz),6.39(d,1H,J=8.7Hz),7.12(d,2H,J=8.1Hz),7.19(d,2H,J=8.1Hz);ESI-MS(m/z,%):278(M
++H);
13C?NMR(75MHz,CDCl
3):δ17.59,19.47,20.77,21.05,23.29,29.24,53.80,79.88,127.72,129.02,135.35,137.33,169.08,171.14;HRMS?C
16H
23NO
3Na(M
++Na):calcd.300.1570,found:300.1573.
Embodiment 24
The ethanoyl product of chirality beta-alkamine is synthetic
Operate the same, productive rate 85%.
[α]
D 20=+127.2(c0.24,CHCl
3);
1H?NMR(300MHz,CDCl
3):δ0.81-1.22(m,6H),1.43-1.55(m,5H),1.93(s,3H),1.96(s,3H),2.34(s,3H),5.17(dd,1H,J=5.7,8.1Hz),5.26(dd,1H,J=5.7,8.1Hz),6.16(d,1H,J=7.2Hz),7.13(d,2H,J=8.1Hz),7.18(d,2H,J=8.1Hz);FT-IR(KBr,cm
-1):3271,2964,1737,1651,1519,1240;ESI-MS(m/z,%):306(M
++H);
13C?NMR(75MHz,CDCl
3):δ10.58,10.91,20.63,20.74,21.01,21.64,23.20,53.67,77.42,127.73,128.91,135.50,137.15,169.05,
170.95;HRMS?C
18H
27NO
3Na(M
++Na):calcd.328.1883,found:328.1884.
Embodiment 25
The ethanoyl product of chirality beta-alkamine is synthetic
Operate the same, productive rate 98%.
[α]
D 20=+116.3(c0.13,CHCl
3);
1H?NMR(300MHz,CDCl
3):δ1.00-1.78(m,11H),1.89(d,3H,J=3.0Hz),1.93(d,3H,J=3.0Hz),2.27(s,3H),4.95(dd,1H,J=4.8,7.2Hz),5.20(dd,1H,J=4.8,8.4Hz),6.35(s,1H),7.07(d,2H,J=8.1Hz),7.13(d,2H,J=8.1Hz);ESI-MS(m/z,%):318(M
++H);
13C?NMR(75MHz,CDCl
3):δ20.80,21.05,23.29,25.55,25.71,26.06,27.87,29.65,38.64,53.26,79.41,127.75,129.02;HRMS?C
19H
28NO
3(M
++H):calcd.318.2064,found:318.2063.
Claims (5)
1. high-optical-purity chiral beta-alkamine compound, its structural formula is as follows:
Perhaps
R wherein
1=C
1-16Straight chain, have the alkyl of side chain or aryl or C
3-6Cycloalkyl; R
2=C
1-12Straight chain, have the alkyl of side chain or aryl, C
3-6Cycloalkyl, or R
3Or R
4The phenyl that replaces; R
3Or R
4=H, C
1-6Alkyl, halogen, C
1-6Alkoxyl group or OCOR
5Described halogen is F, Cl or Br; R
5=C
1-6Alkyl.
2. the preparation method of a high-optical-purity chiral beta-alkamine compound as claimed in claim 1 is characterized in that with structural formula being
Aldehyde and structural formula be
Perhaps
Chirality N-tertiary butyl sulfenimide, under-78 ℃, as reaction reagent, as organic solvent, cross-coupling reaction takes place 1-20 hour with tetrahydrofuran (THF) with samarium diodide in the presence of the trimethyl carbinol or methyl alcohol; R wherein
1And R
2According to claim 1, the mol ratio of described aldehyde, chirality N-tertiary butyl sulfenimide, samarium diodide, the trimethyl carbinol or methyl alcohol is respectively: 1.0: 1.0~3.0: 1.5~2.2: 1.5~2.2.
3. the preparation method of a kind of high-optical-purity chiral beta-alkamine compound as claimed in claim 2 is characterized in that described imines is a chirality N-tertiary butyl sulfenimide.
4. the purposes of a high-optical-purity chiral beta-alkamine compound as claimed in claim 1 is characterized in that being used to prepare structural formula is
Perhaps
The chirality beta-alkamine, R wherein
1And R
2According to claim 1.
5. the purposes of high-optical-purity chiral beta-alkamine compound as claimed in claim 4 is characterized in that chiral beta-alkamine compound as claimed in claim 1 reacted 1-10 hour, removed N-tertiary butyl sulfinyl under acidic conditions.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510027249 CN1281582C (en) | 2005-06-29 | 2005-06-29 | High-optical-purity chiral beta-alkamine compound, preparing method and its use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510027249 CN1281582C (en) | 2005-06-29 | 2005-06-29 | High-optical-purity chiral beta-alkamine compound, preparing method and its use |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1709865A true CN1709865A (en) | 2005-12-21 |
CN1281582C CN1281582C (en) | 2006-10-25 |
Family
ID=35706160
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200510027249 Expired - Fee Related CN1281582C (en) | 2005-06-29 | 2005-06-29 | High-optical-purity chiral beta-alkamine compound, preparing method and its use |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1281582C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104974049B (en) * | 2014-04-09 | 2016-08-31 | 中国科学院化学研究所 | One prepares 1, the method for 5-amino alcohol |
-
2005
- 2005-06-29 CN CN 200510027249 patent/CN1281582C/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104974049B (en) * | 2014-04-09 | 2016-08-31 | 中国科学院化学研究所 | One prepares 1, the method for 5-amino alcohol |
Also Published As
Publication number | Publication date |
---|---|
CN1281582C (en) | 2006-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101080399A (en) | Process for producing optically active epoxy compound, complex for use in the process, and process for producing the same | |
CN1238361C (en) | Spiro-diphosphine ligand | |
CN1869036A (en) | 7-substituted-3-chloro pyrrolo [3,4-b] pyridine compound | |
CN1944406A (en) | Indole heterocyclic compounds and intermediate, and synthetic method | |
CN1927830A (en) | Compound of optically pure sulfenamides and application thereof | |
CN1884290A (en) | Phosphorus-oxazoline ligand with spiro backbone and its uses in asymmetrical catalytic hydrogenation | |
JP2014040457A (en) | Method of manufacturing phosphoroamide compound and optically active alcohol | |
CN1765503A (en) | Quarternary ammonium salt of quinine compound, its preparation method and use | |
CN1281582C (en) | High-optical-purity chiral beta-alkamine compound, preparing method and its use | |
KR101430116B1 (en) | METHOD FOR PREPARING CHIRAL α-AMINO NITRILE USING CATALYST FOR STRECKER REACTION | |
CN101058532A (en) | Method of preparing chiral primary alcohol and secondary alcohol with chirality center at ortho position of hydroxyl group | |
CN101054355A (en) | Compound of optically pure disulfenamides and application thereof | |
EP3106453A1 (en) | Method for producing optically active compound, and novel metal-diamine complex | |
JP5283867B2 (en) | Method for producing optically active β-hydroxycarboxylic acid derivative | |
CN1752062A (en) | Method of synthesizing alpha-functional group multi-substituted propenol | |
CN1803777A (en) | Chemical synthesis method of pyrimidine thioketone | |
CN1160310C (en) | Optically active erhtyro-3-amino-2-hydroxybutyric esters and process for preparing said esters | |
JP2010138136A (en) | Novel phosphine-borane compound, method for producing the same and method for producing hydrogen-phosphine-borane compound | |
CN1166671C (en) | C2 unsymmetric chiral biphosphine ligand and its synthesizing method and application | |
CN1930116A (en) | Chiral tertiary aminoalkylnaphthols | |
CN1288122C (en) | Process for producing carbonyl compound | |
JP2015172024A (en) | Chiral bicyclic diene ligand having hydrogen bond formation amide group | |
WO2003074534A9 (en) | Reagents for asymmetric allylation, aldol, and tandem aldol and allylation reactions | |
CN1305863C (en) | Method for synthesizing (S)-isopropyl-(2-piperidine) phenyl-methylhistamine | |
CN1010006B (en) | Production of chiral rhodium-diphosphine complexes and use in asymmetric hydrogenations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20061025 Termination date: 20170629 |